Saravanan Ponnusamy, Visser Theo J, Dayan Colin M
Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, Dorothy Hodgkin Building, University of Bristol, Whitson Street, Bristol BS1 3NY, United Kingdom.
J Clin Endocrinol Metab. 2006 Sep;91(9):3389-93. doi: 10.1210/jc.2006-0414. Epub 2006 Jun 27.
An association between mood disorders and overt thyroid dysfunction is well established, but there are few data on the potential for thyroid hormone levels closer to the reference range to correlate with psychological well-being.
DESIGN, SETTING, AND PATIENTS: We analyzed the relationship between psychological well-being and free T(4) (fT4), free T(3) (fT3), TSH, and total rT(3) in 697 patients on thyroid hormone replacement therapy at entry to a randomized, controlled trial of combined T(4) and T(3) replacement therapy. All patients were on 100 mug or more T(4).
Psychological well-being was assessed with General Health Questionnaire-12 (GHQ-12), Thyroid Symptom Questionnaire, and Hospital Anxiety and Depression Scale.
fT(4) and TSH showed a strong correlation with GHQ-12 scores (fT4 - b: -0.16, P = 0.005; TSH - b: 0.663, P = 0.04). No correlations were seen between the GHQ scores and fT3 (b: 0.318, P = 0.275), rT(3) (b: 0.095, P = 0.95), rT(3) to fT4 ratio (b: 71.83, P = 0.09) or fT3 to rT(3) ratio (b: 0.05, P = 0.32). The correlations remained when the data set was limited to patients with TSH in the range 0.3-4.0 mIU/liter. Similar correlations were seen with the Thyroid Symptom Questionnaire, although not with the Hospital Anxiety and Depression Scale scores.
Differences in fT4 and TSH concentration, even within the reference range, may be a determinant of psychological well-being in treated hypothyroid patients although not necessarily with symptoms typical of anxiety or depression.
情绪障碍与明显的甲状腺功能障碍之间的关联已得到充分证实,但关于更接近参考范围的甲状腺激素水平与心理健康之间潜在关联的数据却很少。
设计、研究地点与患者:在一项关于联合 T4 和 T3 替代疗法的随机对照试验入组时,我们分析了 697 例接受甲状腺激素替代治疗患者的心理健康与游离 T4(fT4)、游离 T3(fT3)、促甲状腺激素(TSH)和总反 T3(rT3)之间的关系。所有患者均接受 100μg 或更多的 T4。
使用一般健康问卷 -12(GHQ - 12)、甲状腺症状问卷和医院焦虑抑郁量表评估心理健康状况。
fT4 和 TSH 与 GHQ - 12 评分呈强相关性(fT4 - b:-0.16,P = 0.005;TSH - b:0.663,P = 0.04)。GHQ 评分与 fT3(b:0.318,P = 0.275)、rT3(b:0.095,P = 0.95)、rT3 与 fT4 比值(b:71.83,P = 0.09)或 fT3 与 rT3 比值(b:0.05,P = 0.32)之间未见相关性。当数据集仅限于 TSH 在 0.3 - 4.0 mIU/升范围内的患者时,相关性依然存在。甲状腺症状问卷也显示出类似的相关性,尽管与医院焦虑抑郁量表评分无关。
即使在参考范围内,fT4 和 TSH 浓度的差异可能是治疗的甲状腺功能减退患者心理健康的一个决定因素,尽管不一定与焦虑或抑郁的典型症状相关。